Short-course primaquine for the radical cure of Plasmodium vivax malaria: a multicentre, randomised, placebo-controlled non-inferiority trial

Taylor WRJ., Thriemer K., von Seidlein L., Yuentrakul P., Assawariyathipat T., Assefa A., Auburn S., Chand K., Chau NH., Cheah PY., Dong LT., Dhorda M., Degaga TS., Devine A., Ekawati LL., Fahmi F., Hailu A., Hasanzai MA., Hien TT., Khu H., Ley B., Lubell Y., Marfurt J., Mohammad H., Moore KA., Naddim MN., Pasaribu AP., Pasaribu S., Promnarate C., Rahim AG., Sirithiranont P., Solomon H., Sudoyo H., Sutanto I., Thanh NV., Tuyet-Trinh NT., Waithira N., Woyessa A., Yamin FY., Dondorp A., Simpson JA., Baird JK., White NJ., Day NP., Price RN.

DOI

10.1016/s0140-6736(19)31285-1

Type

Journal

The Lancet

Publisher

Elsevier BV

Publication Date

09/2019

Volume

394

Pages

929 - 938

Permalink Original publication